Wave Life Sciences Ltd (WVE) Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Wave Life Sciences Ltd (WVE) following the 2026 Q2 hedge fund 13F filings?

As of today, WVE has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), WVE gained -6.9% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Wave Life Sciences Ltd (WVE)

229 + Investors. Track Smart Money conviction in WVE. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — WVE

Based on 233 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added WVE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

233 hedge funds hold WVE right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +20% more funds vs a year ago

fund count last 6Q

+39 new funds entered over the past year (+20% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟢

More buyers than sellers — 64% buying

163 buying91 selling

Last quarter: 163 funds were net buyers (52 opened a brand new position + 111 added to an existing one). Only 91 were sellers (53 trimmed + 38 sold completely). A clear majority buying is a strong confirmation signal.

⚠️

Fewer new buyers each quarter (-19 vs last Q)

new funds entering per quarter

Funds opening this position for the first time: 24 → 31 → 71 → 52. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.

🔒

45% of holders stayed for 2+ years

■ 45% conviction (2yr+) ■ 25% medium ■ 30% new

105 out of 233 hedge funds have held WVE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

💎

Buying through price weakness — shares -6%, value -99%

Value

-98%

-5%

Last quarter: funds added -6% more shares while total portfolio value only changed -99%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

🚀

Acceleration phase — new buyers rushing in

35 → 24 → 31 → 71 → 52 new funds/Q

New funds entering each quarter: 24 → 31 → 71 → 52. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🏛️

Veteran-anchored — 54% veterans vs 32% newcomers

■ 54% veterans ■ 14% 1-2yr ■ 32% new

Entry-cohort mix of 253 holders: 136 (54%) are 2+ year veterans, 35 entered 1–2 years ago, and 82 (32%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

✅

Strong quality — 29% AUM from major funds

29% from top-100 AUM funds

48 of 230 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

4.2

out of 10

Moderate Exit Risk

Exit risk score 4.2/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	229	218	5.05%
13F Shares	177M	188M	-5.81%
Total Value	$1.20B	$99.27B	-98.79%
New Positions	49	70	-21
Increased Positions	105	80	+25
Closed Positions	38	42	-4
Reduced Positions	48	48	-
Total Calls	14	13	7.69%
Total Puts	9	9	-
PUT/CALL Ratio	0.64	0.69	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

229

218

5.05%

13F Shares

177M

188M

-5.81%

Total Value

$1.20B

$99.27B

-98.79%

New Positions

-21

Increased Positions

105

+25

Closed Positions

-4

Reduced Positions

Total Calls

7.69%

Total Puts

PUT/CALL Ratio

0.64

0.69

Bullish

Institutional Holders (2026 Q2)

229 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in WVE. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 WVE holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	M28 Capital Management LP	56.53%	4,588,284	$26.7M
2	GSK plc	17.60%	18,245,691	$106.0M
3	Pfizer Inc	6.42%	1,875,000	$10.9M
4	683 Capital Management, LLC	1.41%	4,950,000	$28.8M
5	Ishara Investments LP	1.40%	328,000	$1.9M
6	Ra Capital Management, L.P.	1.36%	26,975,505	$156.7M
7	Readystate Asset Management LP	0.94%	4,727,139	$27.5M
8	Maverick Capital Ltd	0.53%	10,278,115	$59.7M
9	Sphera Funds Management LTD.	0.48%	638,272	$3.7M
10	Platinum Investment Management Ltd	0.39%	275,269	$1.6M
11	Bayforest Capital Ltd	0.26%	48,854	$284K
12	Elmind Capital, LP	0.26%	177,846	$1.0M
13	Privium Fund Management B.V.	0.26%	241,010	$1.4M
14	Algert Global LLC	0.19%	2,817,615	$16.4M
15	Driehaus Capital Management LLC	0.18%	5,443,143	$31.6M
16	AlphaCentric Advisors LLC	0.18%	35,670	$207K
17	Emerald Mutual Fund Advisers Trust	0.17%	847,999	$4.9M
18	Emerald Advisers, LLC	0.17%	1,223,965	$7.1M
19	Tang Capital Management LLC	0.16%	600,000	$3.5M
20	Newtyn Management, LLC	0.16%	215,000	$1.2M
21	Bridgefront Capital, LLC	0.16%	101,454	$589K
22	Capstone Capital Management Ltd	0.14%	53,115	$309K
23	Knott David M Jr	0.12%	40,000	$232K
24	Matisse Capital	0.11%	45,723	$266K
25	Carolina Wealth Management Inc	0.09%	32,500	$189K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Wave Life Sciences Ltd (WVE)

What does the Smart Money Trend signal show for WVE?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added WVE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for WVE?

More buyers than sellers — 64% buying: Last quarter: 163 funds were net buyers (52 opened a brand new position + 111 added to an existing one). Only 91 were sellers (53 trimmed + 38 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for WVE holders?

Strong quality — 29% AUM from major funds: 48 of 230 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held WVE?

45% of holders stayed for 2+ years: 105 out of 233 hedge funds have held WVE for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Wave Life Sciences Ltd (WVE) following the 2026 Q2 hedge fund 13F filings?

As of today, WVE has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), WVE has gained -6.9% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Wave Life Sciences Ltd (WVE)

Smart Money Signals — WVE

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Steady growth — +20% more funds vs a year ago

More buyers than sellers — 64% buying

Fewer new buyers each quarter (-19 vs last Q)

45% of holders stayed for 2+ years

Buying through price weakness — shares -6%, value -99%

Acceleration phase — new buyers rushing in

Veteran-anchored — 54% veterans vs 32% newcomers

Strong quality — 29% AUM from major funds

Institutional Sentiment Summary — WVE

Hedge Fund Ownership: WVE

Market Analysis: WVE

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: WVE

Is It Too Late to Buy Wave Life Sciences Ltd (WVE) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: WVE

Statistics: WVE

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Wave Life Sciences Ltd (WVE)

Welcome to 13Foresight!